A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Prostate Cancer|Breast Cancer|Ovarian Cancer|Lung Cancer|Gastric Cancer
Interventions: DRUG: Docetaxel plus lonafarnib
Sponsor: Merck Sharp & Dohme LLC